Literature DB >> 11860713

Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery.

Liang Xu1, Peter Frederik, Kathleen F Pirollo, Wen-Hua Tang, Antonina Rait, Lai-Man Xiang, Weiqun Huang, Idalia Cruz, Yuzhi Yin, Esther H Chang.   

Abstract

Molecular therapy, including gene therapy, is a promising strategy for the treatment of human disease. However, delivery of molecular therapeutics efficiently and specifically to the target tissue remains a significant challenge. A human transferrin (Tf)-targeted cationic liposome-DNA complex, Tf-lipoplex, has shown high gene transfer efficiency and efficacy with human head and neck cancer in vitro and in vivo (Xu, L., Pirollo, K.F., Tang, W.H., Rait, A., and Chang, E.H. Hum. Gene Ther. 1999;10:2941-2952). Here we explore the structure, size, formation process, and structure-function relationships of Tf-lipoplex. We have observed Tf-lipoplex to have a highly compact structure, with a relatively uniform size of 50-90 nm. This nanostructure is novel in that it resembles a virus particle with a dense core enveloped by a membrane coated with Tf molecules spiking the surface. More importantly, compared with unliganded lipoplex, Tf-lipoplex shows enhanced stability, improved in vivo gene transfer efficiency, and long-term efficacy for systemic p53 gene therapy of human prostate cancer when used in combination with conventional radiotherapy. On the basis of our observations, we propose a multistep self-assembly process and Tf-facilitated DNA cocondensation model that may provide an explanation for the resultant small size and effectiveness of our nanostructural Tf-lipoplex system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860713     DOI: 10.1089/10430340252792594

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  32 in total

1.  Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.

Authors:  Yao Dai; Meilan Liu; Wenhua Tang; Jeffrey DeSano; Ezra Burstein; Mary Davis; Kenneth Pienta; Theodore Lawrence; Liang Xu
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

2.  Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo.

Authors:  Chengli Yang; Antonina Rait; Kathleen F Pirollo; John A Dagata; Natalia Farkas; Esther H Chang
Journal:  Nanomedicine       Date:  2008-07-26       Impact factor: 5.307

3.  Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study.

Authors:  Kathleen F Pirollo; John Nemunaitis; Po Ki Leung; Robert Nunan; Jana Adams; Esther H Chang
Journal:  Mol Ther       Date:  2016-06-30       Impact factor: 11.454

4.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

Review 5.  Chemosensitization of prostate cancer by modulating Bcl-2 family proteins.

Authors:  David Karnak; Liang Xu
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

6.  Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer.

Authors:  Yao Dai; Jeffrey Desano; Yang Qu; Wenhua Tang; Yang Meng; Theodore S Lawrence; Liang Xu
Journal:  Am J Cancer Res       Date:  2011       Impact factor: 6.166

Review 7.  Bio-inspired, bioengineered and biomimetic drug delivery carriers.

Authors:  Jin-Wook Yoo; Darrell J Irvine; Dennis E Discher; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

8.  Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo.

Authors:  Kathleen F Pirollo; Antonina Rait; Qi Zhou; Xin-qiao Zhang; Jain Zhou; Chang-Soo Kim; William F Benedict; Esther H Chang
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

9.  Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.

Authors:  Yao Dai; Theodore S Lawrence; Liang Xu
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

10.  MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.

Authors:  Qing Ji; Xinbao Hao; Min Zhang; Wenhua Tang; Meng Yang; Ling Li; Debing Xiang; Jeffrey T Desano; Guido T Bommer; Daiming Fan; Eric R Fearon; Theodore S Lawrence; Liang Xu
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.